Tiger Eye Capital LLC boosted its holdings in shares of UnitedHealth Group (NYSE:UNH) by 36.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 92,514 shares of the healthcare conglomerate’s stock after purchasing an additional 24,514 shares during the period. UnitedHealth Group makes up approximately 3.4% of Tiger Eye Capital LLC’s holdings, making the stock its 15th biggest position. Tiger Eye Capital LLC’s holdings in UnitedHealth Group were worth $20,396,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. Maverick Capital Ltd. acquired a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $4,048,000. Kingdon Capital Management L.L.C. acquired a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $13,841,000. Arrowstreet Capital Limited Partnership raised its holdings in shares of UnitedHealth Group by 30.0% during the second quarter. Arrowstreet Capital Limited Partnership now owns 1,303,068 shares of the healthcare conglomerate’s stock valued at $241,615,000 after acquiring an additional 300,744 shares during the period. Tower Research Capital LLC TRC raised its holdings in shares of UnitedHealth Group by 3,881.4% during the second quarter. Tower Research Capital LLC TRC now owns 6,211 shares of the healthcare conglomerate’s stock valued at $1,152,000 after acquiring an additional 6,055 shares during the period. Finally, Coldstream Capital Management Inc. raised its holdings in shares of UnitedHealth Group by 37.8% during the second quarter. Coldstream Capital Management Inc. now owns 1,698 shares of the healthcare conglomerate’s stock valued at $315,000 after acquiring an additional 466 shares during the period. 86.78% of the stock is owned by institutional investors and hedge funds.
Shares of UNH opened at $230.32 on Tuesday. UnitedHealth Group has a 12 month low of $164.96 and a 12 month high of $250.79. The firm has a market cap of $217,027.44, a PE ratio of 22.87, a price-to-earnings-growth ratio of 1.31 and a beta of 0.77. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th were paid a dividend of $0.75 per share. The ex-dividend date was Thursday, March 8th. This represents a $3.00 annualized dividend and a dividend yield of 1.30%. UnitedHealth Group’s dividend payout ratio (DPR) is 29.79%.
UNH has been the topic of a number of recent analyst reports. Goldman Sachs initiated coverage on shares of UnitedHealth Group in a report on Wednesday, January 3rd. They set a “buy” rating and a $269.00 price target on the stock. Credit Suisse Group restated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 27th. Cantor Fitzgerald restated a “buy” rating and set a $235.00 price target on shares of UnitedHealth Group in a report on Monday, December 25th. Deutsche Bank upped their price objective on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Finally, Citigroup upped their price objective on shares of UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Three equities research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the company. UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $244.62.
In related news, Director William C. Ballard, Jr. sold 10,000 shares of the company’s stock in a transaction on Tuesday, January 23rd. The shares were sold at an average price of $246.38, for a total transaction of $2,463,800.00. Following the completion of the sale, the director now directly owns 76,637 shares of the company’s stock, valued at approximately $18,881,824.06. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Kenneth Irwin Shine sold 198 shares of the company’s stock in a transaction on Friday, January 19th. The stock was sold at an average price of $242.55, for a total transaction of $48,024.90. Following the sale, the director now directly owns 1,790,567 shares of the company’s stock, valued at $434,302,025.85. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 77,015 shares of company stock worth $17,879,199. 0.89% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION NOTICE: “Tiger Eye Capital LLC Acquires 24,514 Shares of UnitedHealth Group (UNH)” was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.chaffeybreeze.com/2018/04/17/tiger-eye-capital-llc-acquires-24514-shares-of-unitedhealth-group-unh.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.